共 221 条
[1]
Anzell AR(2018)Mitochondrial quality control and disease: insights into ischemia-reperfusion injury Mol Neurobiol 55 2547-2564
[2]
Maizy R(2018)A review of GLP-1 receptor agonists: evolution and advancement, through the lens of randomised controlled trials Diabetes Obes Metab 20 22-33
[3]
Przyklenk K(2017)Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial Lancet 390 1664-1675
[4]
Sanderson TH(2019)Sitagliptin and liraglutide modulate L-dopa effect and attenuate dyskinetic movements in rotenone-lesioned rats Neurotox Res 35 635-653
[5]
Aroda VR(2020)Parkinson disease Eur J Neurol 27 27-42
[6]
Athauda D(2020)Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes Brain 143 3067-3076
[7]
Maclagan K(2005)Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise J Physiol 567 349-358
[8]
Skene SS(2013)PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria Science 340 471-475
[9]
Bajwa-Joseph M(2018)Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study Neurology 91 e139-e142
[10]
Letchford D(2018)Neuropathology of Parkinson disease Parkinsonism Relat Disord 46 S30-S33